| Literature DB >> 32532206 |
Nida Buawangpong1, Kanokporn Pinyopornpanish2, Wichuda Jiraporncharoen1, Nisachol Dejkriengkraikul1, Pakorn Sagulkoo3, Chanapat Pateekhum1, Chaisiri Angkurawaranon1.
Abstract
BACKGROUND: Treating hypertensive patients by integrating the patient-centered approach would influence the practice and outcome of treatment. Our purpose was to determine whether the implementation of a patient-centered approach in health care delivery can improve adhering to guidelines and the quality-of-care.Entities:
Keywords: Clinical practice; Family medicine; Guidelines; Hypertension; Patient-centered medicine; Primary health care
Mesh:
Substances:
Year: 2020 PMID: 32532206 PMCID: PMC7293111 DOI: 10.1186/s12875-020-01183-0
Source DB: PubMed Journal: BMC Fam Pract ISSN: 1471-2296 Impact factor: 2.497
Characteristics of the patients in the FM and SS clinics
| Characteristics | FM clinic | SS clinic | |
|---|---|---|---|
| Female gender, n | 55 | 65 | 0.149 |
| Age (year), mean (SD) | 61.68 (6.44) | 52.14 (7.03) | < 0.001a |
| BMI (kg/m2), mean (SD) | 26.10 (4.12) | 26.29 (3.77) | 0.738a |
| Education levelc, n (%) | 0.120 | ||
| - Primary school or lower | 9/30 (30.00) | 27/58 (46.55) | |
| - High school/ Vocational school | 11/30 (36.67) | 22/58 (37.93) | |
| - Bachelor’s degree or higher | 10/30 (33.33) | 9/58 (15.52) | |
| Occupation with regular salaryc, n (%) | 41/69 (59.42) | 16/65 (24.62) | < 0.001 |
| Comorbidities | |||
| ● Diabetic mellitus type II, n | 34 | 39 | 0.463 |
| ● Dyslipidemia, n | 86 | 55 | < 0.001 |
| ● Chronic kidney disease, n | 8 | 4 | 0.234 |
| ● Cerebrovascular disease, n | 9 | 0 | 0.003b |
| ● Cardiovascular disease, n | 6 | 0 | 0.029b |
| Use of anti-hypertensive drugs for 1 year | 92 | 99 | 0.035b |
| Current anti-hypertensive drugs | |||
| ● Calcium channel blockers, n | 62 | 66 | 0.556 |
| ● Beta blockers, n | 6 | 24 | < 0.001 |
| ● ACE inhibitors, n | 9 | 32 | < 0.001 |
| ● Angiotensin II receptor blockers, n | 47 | 25 | 0.001 |
| ● Mineralocorticoid receptor antagonists, n | 1 | 0 | 1.000b |
| ● Diuretics, n | 7 | 12 | 0.228 |
| Active alcohol drinkerc, n (%) | 21/87 (24.0) | 22/100 (22.0) | 0.729 |
| Current smokerc, n (%) | 4/86 (4.65) | 2/100 (2.00) | 0.417b |
| Percentage CV risk calculation, mean (SD) | 12.80 (7.75) | 6.90 (5.28) | < 0.001a |
| Baseline BP (mmHg), mean (SD) | |||
| ● Systolic BP | 134.96 (13.8) | 137.36 (14.5) | 0.232a |
| ● Diastolic BP | 77.76 (10.52) | 82.03 (9.68) | 0.003a |
| Mean BP in 1 year (mmHg), mean (SD) | |||
| ● Systolic BP | 132.71 (10.7) | 134.21 (10.1) | 0.308a |
| ● Diastolic BP | 75.62 (7.21) | 80.98 (7.87) | < 0.001a |
| Mean BP excluding baseline (mmHg), mean (SD) | |||
| ● Systolic BP | 131.99 (11. 2) | 132.90 (10.2) | 0.548a |
| ● Diastolic BP | 74.98 (7.54) | 80.47 (8.64) | < 0.001a |
BMI body mass index, BP blood pressure
a t-test
b Fisher’s exact test
c Evaluated among those with data in electronic records
Evidence of initial assessment on history taking and physical examination
| Evidence of initial assessment on history taking and physical examination | FM clinic N = 100 | SS clinic N = 100 | |
|---|---|---|---|
| History taking | |||
| ● Family history of hypertension, n | 26 | 2 | < 0.001a |
| ● Assessed for secondary hypertension, n | 76 | 60 | 0.015 |
| Physical examination | |||
| ● Evidence of secondary hypertension, n | 3 | 5 | 0.470 |
a Fisher’s exact test
Evidence of continuous monitoring and assessment for target organ damage
| Topics | FM clinic | SS clinic | |
|---|---|---|---|
| History taking | |||
| ● History of hypertension, n | 96 | 78 | 0.001a |
| ● Risk factors, n | 92 | 99 | 0.035a |
| ● Symptoms suggestive of TOD, n | 85 | 65 | 0.001 |
| Physical examination | |||
| ● BP and PR measurement, n | 98 | 100 | 0.497a |
| ● BMI calculation and WC measurement, n | 24 | 2 | < 0.001a |
| ● TOD and cardiovascular disease, n | 85 | 45 | < 0.001 |
| Laboratory investigation | |||
| ● Fasting plasma glucose, n | 93 | 99 | 0.065* |
| ● Serum TC, HDL-C, LDL-C, triglyceride, n | 100 | 100 | N/A |
| ● Serum electrolytes, Cr, GFR calculation, n | 94 | 99 | 0.118a |
| ● Hemoglobin or hematocrit, n | 43 | 43 | 1.000 |
| ● Urinalysis, n | 65 | 59 | 0.382 |
| ● Electrocardiography, n | 28 | 33 | 0.443 |
| ● CV risk assessment at OPD, n | 3 | 1 | 0.621a |
BMI body mass index, BP blood pressure, Cr creatinine, CV risk cardiovascular risk, GFR glomerular filtration rate, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, PR pulse rate, TC total cholesterol, TOD target organ damage, WC waist circumference, OPD outpatient clinic
a Fisher’s exact test
Evidence of giving advice on lifestyle modification
| Topics | FM clinic | SS clinic | |
|---|---|---|---|
| Weight reduction, n | 23 | 1 | < 0.001a |
| Appropriate exercise, n | 51 | 17 | < 0.001 |
| Dietary approach, n | 46 | 27 | 0.005 |
| Limiting of alcohol intake for drinkers, n/No. of drinkers (%) | 10/21 (47.6) | 12/22 (54.5) | 0.663 |
| Smoking cessation for smokers, n/No. of smokers (%) | 1/4 (25.0) | 1/2 (50.0) | 1.000a |
a Fisher’s exact test
Evidence of appropriateness of prescription and adjustment of anti-hypertensive medication
| Topics | FM clinic | SS clinic | |
|---|---|---|---|
| Ever used an anti-hypertensive drug during the last year, n | 92 | 99 | 0.035a |
| Starting with appropriate dosage of medication, n (%) | 91/92 (98.9) | 99/99 (100) | 0.482a |
| Use of an appropriate class at the start, n (%) | 88/92 (95.6) | 94/99 (94.9) | 1.000a |
| Choice of the most appropriate medication for the specific conditions, n (%) | 79/92 (85.9) | 88/99 (88.9) | 0.663 |
| Never used ACEIs together with ARBs, n/No. of patients using more than one type of medication (%) | 34/34 (100) | 47/48 (97.9) | 1.000a |
| Prescription of fixed-dose combinations, n/ No. of patients using more than one type of medication (%) | 12/34 (35.3) | 3/48 (6.25) | 0.001 |
| Adjustment of dosage of medication when blood pressure goal not achieved, n/No. of patients who had ever had uncontrolled BP (%) | 38/63 (60.3) | 24/69 (34.8) | 0.003 |
a Fisher’s exact test